Ronald Blue Trust, Inc. Qiagen N.V. Transaction History

Ronald Blue Trust, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	BUY	$35.55 - $43.57 $101,353 - $124,218	2,851 Added 253.87%	3,974 $161,000
Q3 2023 Oct 11, 2023	BUY	$39.13 - $47.24 $29,230 - $35,288	747 Added 198.67%	1,123 $51,000
Q2 2023 Jul 14, 2023	SELL	$43.93 - $46.76 $53,902 - $57,374	-1,227 Reduced 76.54%	376 $17,000
Q1 2023 Apr 17, 2023	BUY	$45.29 - $50.76 $65,127 - $72,992	1,438 Added 871.52%	1,603 $80,000
Q4 2022 Jan 17, 2023	SELL	$41.91 - $50.48 $8,298 - $9,995	-198 Reduced 54.55%	165 $7,000
Q3 2022 Oct 21, 2022	SELL	$40.9 - $50.42 $899 - $1,109	-22 Reduced 5.71%	363 $17,000
Q2 2022 Aug 09, 2022	BUY	$42.98 - $49.77 $16,547 - $19,161	385 New	385 $19,000

6.34M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $10.2B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Ronald Blue Trust, Inc., based on Form 13F filings with the SEC.

Stay updated on Ronald Blue Trust, Inc. with notifications on news.